Clinical Evaluation of Reverse Versus Anatomic Shoulder Arthroplasty Techniques in the Treatment of Osteoarthritis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorUniversity of Alberta

About this trial

Osteoarthritis (OA) is the most common form of arthritis, affecting millions of people worldwide and it is common in an aging population. Surgical shoulder replacement (arthroplasty) is typically considered when non-surgical measures, such as physiotherapy or medication, have failed. There are two commonly performed surgical replacement procedures in patients who have advanced shoulder OA, and are 65 years of age and older: "Total Shoulder replacement or Arthroplasty (TSA)" and "Reverse Total Shoulder Arthroplasty (RTSA)".

Few studies have compared the two procedures. Surgeons face uncertainty regarding which procedure to perform in patients 65 years of age and older. This pilot Randomized Controlled Trial (RCT) will compare the "TSA" and "RTSA" procedures, in patients 65 years of age and older. Participants will be assigned at random, (like flipping a coin), to one of the two groups (TSA or RTSA). The overall goal of this pilot study is to determine which procedure produces better functional and quality of life outcomes with fewer complications within the first 12-months after surgery. Moreover, pilot data will help determining the feasibility of conducting a larger trial comparing TSA versus RTSA surgical management in 65 years of age and older participants with advanced shoulder OA.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

The use of drugs including analgesics and non-steroidal anti-inflammatory drugs

Physiotherapy consisting of stretching, strengthening and local modalities (ultrasound, cryotherapy, etc.)

Activity modification

Imaging, and intra-operative findings confirming advanced gleno-humeral cartilage loss

Disqualifiers

Active joint or systemic infection

Rotator cuff arthropathy

Need for an augmented glenoid component or a bone graft to correct version to within 10 degrees of neutral

Retroversion cannot be surgically corrected to within 10 degrees of neutral with a "high- side" ream technique

Trial design

Design model

Parallel

Treatments tested in this trial

  • Reverse Total Shoulder Arthroplasty (RTSA)

    Procedure/Surgery

    Patient will undergo a RTSA as per standard technique. It uses a stemmed metal humeral component attached to the glenoid and the shallow glenoid component attached to the humerus. Pre-operative CT imaging and surgical planning software based on pre-operative CT scans will be used in each case to determine the degree of eccentric ("high side") anterior reaming to within \< 10 degrees of neutral glenoid version. Standard instruments including a spherical burr and power reamers will be used to achieve this.

  • Total Shoulder Arthroplasty (TSA)

    Procedure/Surgery

    Patients will undergo standard glenoid preparation and implantation of a TSA. It uses a stemmed metal humeral component to replace the arthritic head of humerus and a shallow polyethylene glenoid component to replace the arthritic glenoid surface. The degree of anterior- reaming will be based on pre-operative CT scan assessment and templating software with the goal of correcting glenoid retroversion to within 10 degrees of neutral version.

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: Reverse Total Shoulder Arthroplasty (RTSA)Experimental treatment 1 intervention
Group B: Total Shoulder Arthroplasty (TSA)Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in Western Ontario Osteoarthritis of the Shoulder (WOOS)

WOOS is a valid, reliable and responsive 19-item self-administered questionnaire that assesses health-related quality of life in patients with osteoathritis undergoing arthroplasty. It consists of 4 domains: pain and physical symptoms; sports, recreation, and work; lifestyle function; and emotional function. The score ranges from 0 to 1,900, with a higher raw score corresponding with the worse outcome.

Time frame
Baseline, 6 weeks, 3-, 6- and 12-months

Secondary outcomes

1

Number of re-operations

Number of re-operations related to their shoulder condition during the first 12-months after surgery.

Time frame
6 weeks, 3-, 6- and 12-months
2

Change in Shoulder Range of Motion (ROM)

Degree of active shoulder flexion, abduction, external and internal rotation using goniometry.

Time frame
Baseline, 6 weeks, 3-, 6- and 12-months
3

Change in Shoulder Pain

Shoulder pain will be assessed using a visual analogue scale (VAS) where zero equals no pain and 10 the worst possible pain. Participants will rate pain at rest, with activity and at night.

Time frame
Baseline, 6 weeks, 3-, 6- and 12-months
4

Change in Shoulder Strength

Isometric shoulder flexion, abduction, external rotation and internal rotation will be measured with the arm in neutral (neutral abduction, 90° elbow flexion), using a dynamometer (microFET3, Hoggan Health Industries Inc., West Jordan, UT). Peak values will be recorded for each contraction that will be held for 3 seconds.

Time frame
Baseline, 6- and 12-months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Alberta

Lead sponsor

University Hospital Foundation

Collaborator

Canadian Orthopaedic Foundation

Collaborator